Symrise stock stands 2.17 percent below its yearly high

Symrise stock stood at EUR 92.94 on September 24, 2026, in intraday trading on Xetra, up 0.56 percent from the previous close. The price was 2.17 percent below the 52-week high of EUR 95.00, leaving the stock close to its yearly peak while the latest company figures provide the fundamental reference point.

Revenue reached EUR 4.929 billion

According to Symrise, fiscal-year 2025 revenue was EUR 4.929 billion. Organic growth reached 2.8 percent in the same period, giving investors a quantified measure of the group performance rather than a purely qualitative outlook.

The company reported a 21.9 percent EBITDA margin for fiscal year 2025, excluding the impairment of its associated company Swedencare. Earnings per share stood at EUR 3.67, while the dividend was EUR 1.25 per share for the same fiscal year.

Specialty chemicals drive the profile

Symrise supplies fragrances, flavor compounds, cosmetic ingredients and functional raw materials to customers in consumer goods, food, beverages, pharmaceuticals and pet nutrition. Its two principal divisions are Taste, Nutrition and Health, and Scent and Care, which spread sales across several end markets.

The company states that it serves more than 6,000 global, regional and local customers with more than 35,000 products. That breadth matters for the stock because the 2.8 percent organic growth figure is tied to a diversified portfolio rather than a single product category.

Stock stays below EUR 95

Symrise stock had a market capitalization of EUR 12,749,525,836 on September 24, 2026. The combination of a 0.56 percent intraday gain and a position 2.17 percent below the 52-week high places the trading picture close to the yearly ceiling, while the 21.9 percent EBITDA margin remains the key profitability reference from fiscal year 2025.